Hence, our hypothesis of different pathogenic mechanisms contributing to circulating n-cfDNA in different COVID-19 patients should be checked in future studies, possibly including the analysis of very specific biomarkers of NETosis such as the plasma levels of citrullinated histone H3 [34] or circulating myeloperoxidase (MPO)-DNA complexes [35]. Here, MPO is linked to COVID-19.